Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Revvity Inc. (RVTY : NYSE)
 
 • Company Description   
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.

Number of Employees: 11,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $156.61 Daily Weekly Monthly
20 Day Moving Average: 1,889,671 shares
Shares Outstanding: 111.59 (millions)
Market Capitalization: $17,475.55 (millions)
Beta: 1.06
52 Week High: $166.25
52 Week Low: $81.22
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 10.20% 9.48%
12 Week 38.14% 30.29%
Year To Date 61.87% 42.85%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
77 4TH AVENUE
-
WALTHAM,MA 02451
USA		 ph: 781-663-6900
fax: 781-663-5985		 steve.willoughby@revvity.com http://www.revvity.com
 
 • General Corporate Information   
Officers
Prahlad Singh - President and Chief Executive Officer
Maxwell Krakowiak - Senior Vice President and Chief Financial Officer
Anita Gonzales - Vice President and Chief Accounting Officer
Peter Barrett - Director
Samuel R. Chapin - Director

Peer Information
Revvity Inc. (CHCR)
Revvity Inc. (ESRX)
Revvity Inc. (MYDP)
Revvity Inc. (COR)
Revvity Inc. (GBCS)
Revvity Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 714046109
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/03/26
Share - Related Items
Shares Outstanding: 111.59
Most Recent Split Date: 6.00 (2.00:1)
Beta: 1.06
Market Capitalization: $17,475.55 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.18%
Current Fiscal Quarter EPS Consensus Estimate: $1.62 Indicated Annual Dividend: $0.28
Current Fiscal Year EPS Consensus Estimate: $5.36 Payout Ratio: 0.05
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 10.25% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/03/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 29.21
Trailing 12 Months: 29.27
PEG Ratio: 2.85
Price Ratios
Price/Book: 2.42
Price/Cash Flow: 17.76
Price / Sales: 6.00
EPS Growth
vs. Year Ago Period: 19.49%
vs. Previous Quarter: 33.02%
Sales Growth
vs. Year Ago Period: 1.31%
vs. Previous Quarter: 2.61%
ROE
09/30/26 - -
06/30/26 - 8.34
03/31/26 - 8.00
ROA
09/30/26 - -
06/30/26 - 5.01
03/31/26 - 4.83
Current Ratio
09/30/26 - -
06/30/26 - 1.80
03/31/26 - 1.72
Quick Ratio
09/30/26 - -
06/30/26 - 1.50
03/31/26 - 1.41
Operating Margin
09/30/26 - -
06/30/26 - 20.80
03/31/26 - 20.23
Net Margin
09/30/26 - -
06/30/26 - 8.16
03/31/26 - 8.26
Pre-Tax Margin
09/30/26 - -
06/30/26 - 8.96
03/31/26 - 9.16
Book Value
09/30/26 - -
06/30/26 - 64.80
03/31/26 - 64.24
Inventory Turnover
09/30/26 - -
06/30/26 - 3.44
03/31/26 - 3.45
Debt-to-Equity
09/30/26 - -
06/30/26 - 0.36
03/31/26 - 0.37
Debt-to-Capital
09/30/26 - -
06/30/26 - 26.70
03/31/26 - 26.82
 

Powered by Zacks Investment Research ©